12/18
08:05 am
pulm
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
High
Report
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
12/3
04:33 pm
pulm
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
02:52 pm
pulm
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
02:05 pm
pulm
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/31
01:05 pm
pulm
Pulmatrix (NASDAQ:PULM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pulmatrix (NASDAQ:PULM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/16
08:05 am
pulm
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
Medium
Report
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets